Stock Ticker

  • Loading stock data...

Merck & Co., Inc. (NYSE:MRK) Achieves Limited Success Of Steglatro In Reducing The Risk Of Patients With Total Hospitalizations

Merck & Co., Inc.  (NYSE:MRK) reported only limited success in lowering patients’ total hospitalizations with heart failures. According to recent clinical data, Merck’s Steglatro could overall reduce cardiovascular death or total hospitalization risks by just 17% or lower the risk of the patient by 30%. In a statement, Merck said the first hospitalizations rate remains […]

Sign Up To Get Our Latest Stocks Alerts